"PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response
"PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response
复制标题
"PrEP 还没有为我们的社区做好准备，我们的社区也没有为 PrEP 做好准备'：注射吸毒者艾滋病毒暴露前预防以及艾滋病毒预防对策的局限性
DOI：
10.1111/add.13437
复制
发表时间：
2017-04-01
期刊：
影响因子：
6
通讯作者：
Strathdee, Steffanie A.
中科院分区：
文献类型：
--
作者：
Guise, Andy;Albers, Eliot Ross;Strathdee, Steffanie A.
背景和目的HIV暴露前预防（Pre-exposure prophylaxis for HIV，简称PrEP）是指HIV阴性者使用抗逆转录病毒药物来保护自己免受HIV感染。PrEP已显示出预防艾滋病毒感染的有效性。尽管有潜力，但注射毒品者（PWID）及其组织表达了许多担忧。有必要听取这些意见，并确保将其纳入政策和战略。本文介绍了PWID对PrEP的看法，以促进将这些意见纳入围绕PrEPMethods的科学和政策辩论中，对由国际吸毒者网络（INPUD）领导的社区咨询报告进行了批判性分析。ResultsThe INPUD报告强调了PWID对PrEP的热情，但也有三个主要问题：PrEP的可行性和伦理，其作为其他减少伤害策略的替代品的潜在用途，以及对PrEP的关注如何预示着艾滋病毒的再医疗化。每一个问题都涉及到明显的差距，在基本服务或反对减少伤害和PWID的humanrights.ConclusionsPeople使用药物的人有根本的关注的潜在影响，暴露前预防艾滋病毒，反映了断层线'在艾滋病毒预防：生物医学的方法在社区的观点占主导地位。需要社区更多地参与艾滋病毒预防战略，否则我们就有可能继续忽视就艾滋病毒流行病的根本结构驱动因素和社会背景采取行动的必要性。
Background and aimsPre-exposure prophylaxis for HIV, or PrEP', is the use of antiretroviral medicines by people who are HIV-negative to protect themselves against acquiring HIV. PrEP has shown efficacy for preventing HIV acquisition. Despite the potential, many concerns have been voiced by people who inject drugs (PWID) and their organizations. There is a need to engage with these views and ensure their integration in to policy and strategy. This paper presents PWID views on PrEP to foster the uptake of these opinions into scientific and policy debate around PrEPMethodsCritical analysis of a report of a community consultation led by the International Network of People who Use Drugs (INPUD).ResultsThe INPUD report highlights enthusiasm from PWID for PrEP, but also three main concerns: the feasibility and ethics of PrEP, its potential use as a substitute for other harm reduction strategies and how a focus on PrEP heralds a re-medicalization of HIV. Each concern relates to evidenced gaps in essential services or opposition to harm reduction and PWID human rights.ConclusionsPeople who use drugs have fundamental concerns about the potential impacts of pre-exposure prophylaxis for HIV which reflect a fault line' in HIV prevention: a predominance of biomedical approaches over community perspectives. Greater community engagement in HIV prevention strategy is needed, or we risk continuing to ignore the need for action on the underlying structural drivers and social context of the HIV epidemic.